1. A time scaling approach to develop an in vitro–in vivo correlation (IVIVC) model using a convolution-based technique

   • Cian Costello
   • Stefaan Rossenu
   • Adrian Dunne

   OriginalPaper 07 July 2011 Pages: 519 - 539

   

2. Population pharmacokinetic–pharmacodynamic analysis of vernakalant hydrochloride injection (RSD1235) in atrial fibrillation or atrial flutter

   • Zhongping Mao
   • Jeff J. Wheeler
   • James J. Keirns

   OriginalPaper 24 July 2011 Pages: 541 - 562

   

3. A Bayesian population analysis of the development of type 2 diabetes in the offspring of diabetic parents

   • C. W. Lin
   • J. H. Warram
   • P. Veng-Pedersen

   OriginalPaper 11 August 2011 Pages: 563 - 579

   

4. Potential errors in the volume of distribution estimation of therapeutic proteins composed of differently cleared components

   • Wolfgang F. Richter
   • Hans Peter Grimm
   • Frank-Peter Theil

   OriginalPaper 21 July 2011 Pages: 581 - 593

   

5. Modelling of the outcome of non-inferiority trials by integration of historical data

   • Alberto Russu
   • Erik van Zwet
   • Oscar Della Pasqua

   OriginalPaper Open access 21 August 2011 Pages: 595 - 612

   

6. A Bayesian hierarchical nonlinear mixture model in the presence of artifactual outliers in a population pharmacokinetic study

   • Leena Choi
   • Brian S. Caffo
   • C. Michael Stein

   OriginalPaper 17 August 2011 Pages: 613 - 636

   

7. Physiologically based pharmacokinetic modeling of SNU-0039, an anti-Alzheimer’s agent, in rats

   • Kyeong-Ryoon Lee
   • Yoon-Jee Chae
   • Suk-Jae Chung

   OriginalPaper 25 August 2011 Pages: 637 - 651

   

8. Allometric scaling of pegylated liposomal anticancer drugs

   • Whitney P. Caron
   • Harvey Clewell
   • William C. Zamboni

   OriginalPaper 24 August 2011 Pages: 653 - 669